Updated:
Luminous Ventures
Luminous Ventures is a London-based fund investing in Deep Tech with a focus on the application of innovative technologies to healthcare and life sciences.
Luminous Ventures
Luminous Ventures is a London-based fund investing in Deep Tech with a focus on the application of innovative technologies to healthcare and life sciences. It invests at Seed and Series A and has backed companies in Europe and North America. The fund is now fully deployed and not making any new investments.
General information
Firm type
Venture Capital
Year founded
2018
Location
Region
Europe
Country
United Kingdom
City
London
Corporate office
London, United Kingdom
Principals
Lomax Ward
General Partner
Sector focus
Frequently asked questions
Who makes investment decisions at Luminous Ventures?
Lomax Ward serves as General Partner and leads investment decisions. Prior to Luminous, Ward operated in the health-tech space as an entrepreneur, which informs the firm's posture of evaluating scientific founders as peer operators rather than purely financial sponsors. The firm has not disclosed additional GPs or an investment committee structure.
Does Luminous fund software companies or exclusively deep-tech labs?
The firm's mandate is weighted toward frontier technology — synthetic biology, precision medicine, advanced computing — but it does back software where the code addresses a deep-tech vertical. Orbital Witness, a legal-tech platform applying machine learning to real estate due diligence, sits in the portfolio alongside life-science companies, demonstrating flexibility at the application layer.
Which geographies does Luminous Ventures focus on?
Luminous concentrates on the United Kingdom, particularly the golden-triangle universities of Oxford, Cambridge, and London, and extends selectively into Nordic deep-tech hubs. The firm sources through principal investigators and technology-transfer offices rather than relying on the generalist European accelerator circuit.
How does Luminous source its deal flow?
Deal flow is built on relationships with academic researchers, postdoctoral labs, and university technology-transfer offices. By evaluating published papers, filed patents, and bench strength as primary due-diligence inputs, the firm accesses startups that often have not yet appeared on demo-day stages or generalist VC radar.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: